BerandaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹724,20
Rentang hari
₹719,65 - ₹754,00
Rentang tahun
₹603,80 - ₹1.997,40
Kapitalisasi pasar
37,97Â M INR
Volume Rata-Rata
200,03Â rb
Rasio P/E
38,09
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,37Â M | 9,39% |
Biaya operasional | 803,51Â jt | 65,13% |
Laba bersih | 222,95Â jt | -33,50% |
Margin laba bersih | 9,39 | -39,18% |
Penghasilan per saham | 4,40 | — |
EBITDA | 277,48Â jt | -6,06% |
Tarif pajak efektif | -0,18% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,80Â M | 4.868,40% |
Total aset | 16,88Â M | 8,63% |
Total liabilitas | 4,21Â M | 9,42% |
Total ekuitas | 12,67 M | — |
Saham yang beredar | 50,67 jt | — |
Harga terhadap nilai buku | 2,90 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 3,38% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 222,95Â jt | -33,50% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Didirikan
1992
Situs
Karyawan
871
